Search by Drug Name or NDC
NDC 00178-0500-01 Lithostat 250 mg/1 Details
Lithostat 250 mg/1
Lithostat is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mission Pharmacal Company. The primary component is ACETOHYDROXAMIC ACID.
Product Information
| NDC | 00178-0500 |
|---|---|
| Product ID | 0178-0500_0e767659-f96a-7c88-e063-6294a90a0f64 |
| Associated GPIs | 56600020000310 |
| GCN Sequence Number | 003144 |
| GCN Sequence Number Description | acetohydroxamic acid TABLET 250 MG ORAL |
| HIC3 | D9A |
| HIC3 Description | AMMONIA INHIBITORS |
| GCN | 10230 |
| HICL Sequence Number | 001397 |
| HICL Sequence Number Description | ACETOHYDROXAMIC ACID |
| Brand/Generic | Brand |
| Proprietary Name | Lithostat |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | acetohydroxamic acid |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/1 |
| Substance Name | ACETOHYDROXAMIC ACID |
| Labeler Name | Mission Pharmacal Company |
| Pharmaceutical Class | Urease Inhibitor [EPC], Urease Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA018749 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 00178-0500-01 (00178050001)
| NDC Package Code | 0178-0500-01 |
|---|---|
| Billing NDC | 00178050001 |
| Package | 100 TABLET in 1 BOTTLE (0178-0500-01) |
| Marketing Start Date | 1983-05-31 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |